Variant report
Variant | nsv961863 |
---|---|
Chromosome Location | chr2:110489979-110504065 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:223)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:110303139..110304334-chr2:110493545..110494430,6 | MCF-7 | breast: | |
2 | chr2:110303649..110304318-chr2:110493558..110494245,2 | K562 | blood: | |
3 | chr2:110273703..110274218-chr2:110493544..110494330,2 | MCF-7 | breast: | |
4 | chr2:110273525..110274131-chr2:110493868..110494433,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RGPD5-1 | chr2:110490308-110490713 | NONHSAT073149 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL22P11 | TF binding region |
ENSG00000233307 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181490493 | chr2:110489984-110489985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs373632761 | chr2:110490001-110490002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577077036 | chr2:110490031-110490032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533620672 | chr2:110490034-110490035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566961420 | chr2:110490058-110490059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185734193 | chr2:110490087-110490088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553284552 | chr2:110490105-110490106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553484775 | chr2:110490117-110490118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576420793 | chr2:110490133-110490134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs141435921 | chr2:110490142-110490143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs4953771 | chr2:110490157-110490158 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs576218137 | chr2:110490178-110490179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs79136847 | chr2:110490179-110490180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs529804909 | chr2:110490182-110490183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs75674849 | chr2:110490198-110490199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543004186 | chr2:110490202-110490203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563291878 | chr2:110490212-110490213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575996128 | chr2:110490221-110490222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532186232 | chr2:110490226-110490227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552485869 | chr2:110490243-110490244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs35656289 | chr2:110490244-110490245 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs188632414 | chr2:110490288-110490289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181100695 | chr2:110490289-110490290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568424522 | chr2:110490291-110490292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186246119 | chr2:110490292-110490293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190766336 | chr2:110490298-110490299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184159648 | chr2:110490442-110490443 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs539473009 | chr2:110490443-110490444 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs553219510 | chr2:110490460-110490461 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs573216651 | chr2:110490494-110490495 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs542125268 | chr2:110490563-110490564 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs542016196 | chr2:110490608-110490609 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs140812526 | chr2:110490609-110490610 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs575793599 | chr2:110490611-110490612 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs543496054 | chr2:110490620-110490621 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs563407239 | chr2:110490656-110490657 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs532124515 | chr2:110490688-110490689 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs150147065 | chr2:110490691-110490692 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs138416553 | chr2:110490696-110490697 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs528407630 | chr2:110490733-110490734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374898352 | chr2:110490757-110490758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536086880 | chr2:110490758-110490759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs35973662 | chr2:110490773-110490774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs548035132 | chr2:110490780-110490781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186383940 | chr2:110490983-110490984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs190890146 | chr2:110490984-110490985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs200258509 | chr2:110491013-110491014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs71383884 | chr2:110491014-110491015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs34461356 | chr2:110491022-110491023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551030036 | chr2:110491036-110491037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Astrocytoma | 22246337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ocular motor apraxia | 21572526 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Idiopathic chronic pancreatitis | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
Maculopathy | 20981449 | CNVD |
Nephronophthisis | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Autism | 22495309 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Ischaemic stroke | 16980335 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Nephronophthisis | 17901113 | CNVD |
Autism | 22549408 | CNVD |
Autism | 21865298 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:110487800-110493800 | Weak transcription | Esophagus | oesophagus |
2 | chr2:110493400-110493800 | Enhancers | HepG2 | liver |
3 | chr2:110493600-110494000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr2:110493600-110494000 | Enhancers | Skeletal Muscle Female | skeletal muscle |
5 | chr2:110493600-110494200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
6 | chr2:110493600-110494200 | Enhancers | NHEK | skin |
7 | chr2:110493800-110494000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr2:110493800-110494000 | Enhancers | Rectal Smooth Muscle | rectum |
9 | chr2:110493800-110494000 | Flanking Active TSS | HepG2 | liver |
10 | chr2:110493800-110494200 | Enhancers | Adipose Nuclei | Adipose |
11 | chr2:110493800-110494200 | Enhancers | Esophagus | oesophagus |
12 | chr2:110494000-110494200 | Enhancers | A549 | lung |
13 | chr2:110494000-110494200 | Enhancers | HepG2 | liver |
14 | chr2:110494000-110494200 | Flanking Active TSS | Osteobl | bone |
15 | chr2:110494000-110494400 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr2:110494000-110494400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
17 | chr2:110494000-110494400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
18 | chr2:110494200-110494400 | Flanking Active TSS | HepG2 | liver |
19 | chr2:110494200-110494400 | Active TSS | Osteobl | bone |